RAMIRO GARZON, M.D.
Osteopathic Medicine at 10 Ave, Columbus, OH
License number
Ohio 35.088651
Category
Osteopathic Medicine
Type
Medical Oncology
License number
Ohio 35088651
Category
Osteopathic Medicine
Type
Hematology
Address
Address
W 10Th Ave, Columbus, OH 43210
Phone
(614) 293-8619
(614) 293-6420 (Fax)
(614) 947-3700
(614) 947-3771 (Fax)
(614) 293-6420 (Fax)
(614) 947-3700
(614) 947-3771 (Fax)
Personal information
See more information about RAMIRO GARZON at radaris.comName
Address
Phone
2582 Henthorn Rd, Columbus, OH 43221
Columbus, OH
1999 Langham Rd, Columbus, OH 43221
Organization information
See more information about RAMIRO GARZON at bizstanding.comRamiro Garzon MD
300 W 10 Ave, Columbus, OH 43210
Industry:
Internist
Phone:
(614) 293-8619 (Phone)
Ramiro Garzon
Professional information
Dr. Ramiro Garzon, Columbus OH - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
460 W 12Th Ave, Columbus 43210
(614) 366-2261 (Phone), (614) 293-7526 (Fax)
ARTHUR G JAMES CANCER HOSPITAL
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone), (614) 798-7945 (Fax)
(614) 366-2261 (Phone), (614) 293-7526 (Fax)
ARTHUR G JAMES CANCER HOSPITAL
300 W 10Th Ave, Columbus 43210
(614) 293-8619 (Phone), (614) 798-7945 (Fax)
Certifications:
Internal Medicine, 2002, Medical Oncology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
460 W 12Th Ave, Columbus 43210
ARTHUR G JAMES CANCER HOSPITAL
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
ARTHUR G JAMES CANCER HOSPITAL
300 W 10Th Ave, Columbus 43210
James Cancer Hospital and Solove Research Institute
300 West 10Th Ave, Columbus 43210
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
Universidad Nacional De Cordoba, Facultad De Ciencias Medicas
Graduated: 1994
Universidad Nacional De Cordoba, Facultad De Ciencias Medicas
Graduated: 1994
Assistant Professor Pf Medicine At The Ohio State University Medical Center
Location:
Columbus, Ohio Area
Industry:
Hospital & Health Care
Ramiro Garzon, Columbus OH
Specialties:
Internist
Address:
300 W 10Th Ave, Columbus, OH 43210
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
8492083, Jul 23, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595207
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 6, 435325, 435375, 536 245, 536 2431, 536 241
Abstract:
Described herein is a method of decreasing expression of HOXA1 in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a HOXA1 gene product where an effective amount of at least one miR-10a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the HOXA1 gene product in the subject.
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
8486913, Jul 16, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595204
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University - Columbus OH
International Classification:
A61K 48/00
US Classification:
514 44, 536 245, 536 2431, 536 241
Abstract:
Described herein is a method of decreasing expression of HOXA1 in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a HOXA1 gene product where an effective amount of at least one miR-10a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the HOXA1 gene product in the subject.
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
8486912, Jul 16, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595200
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K 48/00
US Classification:
514 44, 536 245, 536 2431, 536 241
Abstract:
Described herein is a method of decreasing expression of MAFB in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a MAFB gene product where an effective amount of at least one miR-130a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the MAFB gene product in the subject.
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
8354224, Jan 15, 2013
Filed:
Jun 27, 2011
Appl. No.:
13/169184
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 6, 435325, 435375
Abstract:
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
2013027, Oct 17, 2013
Filed:
Jun 25, 2013
Appl. No.:
13/925954
Inventors:
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
George A. Calin - Pearland TX, US
International Classification:
C12N 15/113, A61K 31/7105, A61K 45/06
US Classification:
424450, 514 44 A, 514 27, 514 34, 424649, 514 199, 424616, 4241331, 536 245, 514 44 R, 514 196
Abstract:
Described herein is a pharmaceutical composition for treating a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a HOXA1 gene product where an effective amount of at least one miR-10a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the HOXA1 gene product in the subject.
Methods And Compositions For Modulating Acute Graft-Versus-Host Disease Using Mir-155 Specific Inhibitors
US Patent:
2013023, Sep 12, 2013
Filed:
Mar 12, 2013
Appl. No.:
13/795879
Inventors:
Ramiro Garzon - Columbus OH, US
Assignee:
THE OHIO STATE UNIVERSITY - Columbus OH
International Classification:
A61K 31/7088
US Classification:
4241331, 514 44 A, 536 245, 4242781, 4241581, 4241731, 424 937, 424549, 424577, 424571, 424569, 424574, 424548, 424558, 424557, 424553, 424551, 424556, 424579, 424580, 424 9371
Abstract:
Methods and compositions for treating or preventing acute graft-versus-host disease (aGVHD) in a subject using miR-155 specific inhibitors are described.
Microrna Fingerprints During Human Megakaryocytopoiesis
US Patent:
2013027, Oct 17, 2013
Filed:
Jun 25, 2013
Appl. No.:
13/925957
Inventors:
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
George A. Calin - Pearland TX, US
International Classification:
C12Q 1/68
US Classification:
506 9, 435 612, 435 611
Abstract:
Described herein are methods of diagnosing a cancer and/or myeloproliferative disorder using microRNAs. Also described are compositions and methods related to cancers and myeloproliferative disorders.